Inhibition of Breast Cancer Resistance Protein and Multidrug Resistance Associated Protein 2 by Natural Compounds and Their Derivatives

Molecular Pharmaceutics

Volumn 14, Issue 1, 2017, Pages 135-146

  Sjöstedt, Noora ^a   Holvikari, Kira ^a   Tammela, Päivi ^a   Kidron, Heidi ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

ABCC2; ABCG2; flavonoid; membrane vesicle; polyphenol; structure activity

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; GALLIC ACID DERIVATIVE; GOSSYPINE; MORIN; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 2; MYRICETIN; NORDIHYDROGUAIARETIC ACID; SILIBININ; BIOLOGICAL PRODUCT; CARRIER PROTEIN; COMPLEMENTARY DNA; FLAVONOID; GALLIC ACID; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN 2; OCTYL GALLATE; TUMOR PROTEIN;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG INHIBITION; FOOD DRUG INTERACTION; IC50; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; SF9 CELL LINE; STRUCTURE ACTIVITY RELATION; TRANSPORT ASSAY; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; BREAST TUMOR; CELL LINE; CHEMISTRY; DIET THERAPY; DRUG EFFECTS; HUMAN; METABOLISM; PHYSIOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; ATP BINDING CASSETTE TRANSPORTER, SUB-FAMILY G, MEMBER 2; BIOLOGICAL PRODUCTS; BIOLOGICAL TRANSPORT; BREAST NEOPLASMS; CELL LINE; DNA, COMPLEMENTARY; FLAVONOIDS; FOOD-DRUG INTERACTIONS; GALLIC ACID; HUMANS; MASOPROCOL; MEMBRANE TRANSPORT PROTEINS; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; SF9 CELLS;

EID: 85008958205     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/acs.molpharmaceut.6b00754     Document Type: Article

References (52)

1. Arts, I. C.; Hollman, P. C. Polyphenols and disease risk in epidemiologic studies Am. J. Clin. Nutr. 2005, 81 (1 Suppl.) 317S-325S
2. Yao, L. H.; Jiang, Y. M.; Shi, J.; Tomas-Barberan, F. A.; Datta, N.; Singanusong, R.; Chen, S. S. Flavonoids in food and their health benefits Plant Foods Hum. Nutr. 2004, 59 (3) 113-22 10.1007/s11130-004-0049-7
3. Tsao, R. Chemistry and biochemistry of dietary polyphenols Nutrients 2010, 2 (12) 1231-46 10.3390/nu2121231
4. Morris, M. E.; Zhang, S. Flavonoid-drug interactions: effects of flavonoids on ABC transporters Life Sci. 2006, 78 (18) 2116-30 10.1016/j.lfs.2005.12.003
5. Tucker, T. G.; Milne, A. M.; Fournel-Gigleux, S.; Fenner, K. S.; Coughtrie, M. W. Absolute immunoquantification of the expression of ABC transporters P-glycoprotein, breast cancer resistance protein and multidrug resistance-associated protein 2 in human liver and duodenum Biochem. Pharmacol. 2012, 83 (2) 279-85 10.1016/j.bcp.2011.10.017
6. Drozdzik, M.; Groer, C.; Penski, J.; Lapczuk, J.; Ostrowski, M.; Lai, Y.; Prasad, B.; Unadkat, J. D.; Siegmund, W.; Oswald, S. Protein abundance of clinically relevant multidrug transporters along the entire length of the human intestine Mol. Pharmaceutics 2014, 11 (10) 3547-55 10.1021/mp500330y
7. Groer, C.; Bruck, S.; Lai, Y.; Paulick, A.; Busemann, A.; Heidecke, C. D.; Siegmund, W.; Oswald, S. LC-MS/MS-based quantification of clinically relevant intestinal uptake and efflux transporter proteins J. Pharm. Biomed. Anal. 2013, 85, 253-61 10.1016/j.jpba.2013.07.031
8. Mao, Q.; Unadkat, J. D. Role of the breast cancer resistance protein (BCRP/ABCG2) in drug transport - an update AAPS J. 2015, 17 (1) 65-82 10.1208/s12248-014-9668-6
9. Imai, Y.; Asada, S.; Tsukahara, S.; Ishikawa, E.; Tsuruo, T.; Sugimoto, Y. Breast cancer resistance protein exports sulfated estrogens but not free estrogens Mol. Pharmacol. 2003, 64 (3) 610-8
10. Chen, Z. S.; Robey, R. W.; Belinsky, M. G.; Shchaveleva, I.; Ren, X. Q.; Sugimoto, Y.; Ross, D. D.; Bates, S. E.; Kruh, G. D. Transport of methotrexate, methotrexate polyglutamates, and 17beta-estradiol 17-(beta- d -glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transport Cancer Res. 2003, 63 (14) 4048-54
11. Jemnitz, K.; Heredi-Szabo, K.; Janossy, J.; Ioja, E.; Vereczkey, L.; Krajcsi, P. ABCC2/Abcc2: a multispecific transporter with dominant excretory functions Drug Metab. Rev. 2010, 42 (3) 402-36 10.3109/03602530903491741
12. Li, Y.; Revalde, J. L.; Reid, G.; Paxton, J. W. Interactions of dietary phytochemicals with ABC transporters: possible implications for drug disposition and multidrug resistance in cancer Drug Metab. Rev. 2010, 42 (4) 590-611 10.3109/03602531003758690
13. Alvarez, A. I.; Real, R.; Perez, M.; Mendoza, G.; Prieto, J. G.; Merino, G. Modulation of the activity of ABC transporters (P-glycoprotein, MRP2, BCRP) by flavonoids and drug response J. Pharm. Sci. 2010, 99 (2) 598-617 10.1002/jps.21851
14. Brand, W.; Schutte, M. E.; Williamson, G.; van Zanden, J. J.; Cnubben, N. H.; Groten, J. P.; van Bladeren, P. J.; Rietjens, I. M. Flavonoid-mediated inhibition of intestinal ABC transporters may affect the oral bioavailability of drugs, food-borne toxic compounds and bioactive ingredients Biomed. Pharmacother. 2006, 60 (9) 508-19 10.1016/j.biopha.2006.07.081
15. Li, Y.; Lu, J.; Paxton, J. W. The role of ABC and SLC transporters in the pharmacokinetics of dietary and herbal phytochemicals and their interactions with xenobiotics Curr. Drug Metab. 2012, 13 (5) 624-39
16. Manach, C.; Donovan, J. L. Pharmacokinetics and metabolism of dietary flavonoids in humans Free Radic. Res. 2004, 38 (8) 771-85 10.1080/10715760410001727858
17. Gurley, B. J. Pharmacokinetic herb-drug interactions (part 1): origins, mechanisms, and the impact of botanical dietary supplements Planta Med. 2012, 78 (13) 1478-89 10.1055/s-0031-1298273
18. Lee, C. A.; O'Connor, M. A.; Ritchie, T. K.; Galetin, A.; Cook, J. A.; Ragueneau-Majlessi, I.; Ellens, H.; Feng, B.; Taub, M. E.; Paine, M. F.; Polli, J. W.; Ware, J. A.; Zamek-Gliszczynski, M. J. Breast cancer resistance protein (ABCG2) in clinical pharmacokinetics and drug interactions: practical recommendations for clinical victim and perpetrator drug-drug interaction study design Drug Metab. Dispos. 2015, 43 (4) 490-509 10.1124/dmd.114.062174
19. Newman, D. J.; Cragg, G. M. Natural products as sources of new drugs over the 30 years from 1981 to 2010 J. Nat. Prod. 2012, 75 (3) 311-35 10.1021/np200906s
20. Zhang, S.; Yang, X.; Morris, M. E. Flavonoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport Mol. Pharmacol. 2004, 65 (5) 1208-16
21. Katayama, K.; Masuyama, K.; Yoshioka, S.; Hasegawa, H.; Mitsuhashi, J.; Sugimoto, Y. Flavonoids inhibit breast cancer resistance protein-mediated drug resistance: transporter specificity and structure-activity relationship Cancer Chemother. Pharmacol. 2007, 60 (6) 789-97 10.1007/s00280-007-0426-7
22. Juvale, K.; Stefan, K.; Wiese, M. Synthesis and biological evaluation of flavones and benzoflavones as inhibitors of BCRP/ABCG2 Eur. J. Med. Chem. 2013, 67, 115-26 10.1016/j.ejmech.2013.06.035
23. Imai, Y.; Tsukahara, S.; Asada, S.; Sugimoto, Y. Phytoestrogens/flavonoids reverse breast cancer resistance protein/ABCG2-mediated multidrug resistance Cancer Res. 2004, 64 (12) 4346-52
24. Matsson, P.; Pedersen, J. M.; Norinder, U.; Bergstrom, C. A.; Artursson, P. Identification of novel specific and general inhibitors of the three major human ATP-binding cassette transporters P-gp, BCRP and MRP2 among registered drugs Pharm. Res. 2009, 26 (8) 1816-31 10.1007/s11095-009-9896-0
25. Doyle, L. A.; Yang, W.; Abruzzo, L. V.; Krogmann, T.; Gao, Y.; Rishi, A. K.; Ross, D. D. A multidrug resistance transporter from human MCF-7 breast cancer cells Proc. Natl. Acad. Sci. U. S. A. 1998, 95 (26) 15665-70 10.1073/pnas.95.26.15665
26. Kidron, H.; Wissel, G.; Manevski, N.; Hakli, M.; Ketola, R. A.; Finel, M.; Yliperttula, M.; Xhaard, H.; Urtti, A. Impact of probe compound in MRP2 vesicular transport assays Eur. J. Pharm. Sci. 2012, 46 (1-2) 100-5 10.1016/j.ejps.2012.02.016
27. Chu, X. Y.; Huskey, S. E.; Braun, M. P.; Sarkadi, B.; Evans, D. C.; Evers, R. Transport of ethinylestradiol glucuronide and ethinylestradiol sulfate by the multidrug resistance proteins MRP1, MRP2, and MRP3 J. Pharmacol. Exp. Ther. 2004, 309 (1) 156-64
28. Telbisz, A.; Muller, M.; Ozvegy-Laczka, C.; Homolya, L.; Szente, L.; Varadi, A.; Sarkadi, B. Membrane cholesterol selectively modulates the activity of the human ABCG2 multidrug transporter Biochim. Biophys. Acta, Biomembr. 2007, 1768 (11) 2698-713 10.1016/j.bbamem.2007.06.026
29. Yap, C. W. PaDEL-descriptor: an open source software to calculate molecular descriptors and fingerprints J. Comput. Chem. 2011, 32 (7) 1466-74 10.1002/jcc.21707
30. Hendrich, A. B. Flavonoid-membrane interactions: possible consequences for biological effects of some polyphenolic compounds Acta Pharmacol. Sin. 2006, 27 (1) 27-40 10.1111/j.1745-7254.2006.00238.x
31. Cooray, H. C.; Janvilisri, T.; van Veen, H. W.; Hladky, S. B.; Barrand, M. A. Interaction of the breast cancer resistance protein with plant polyphenols Biochem. Biophys. Res. Commun. 2004, 317 (1) 269-75 10.1016/j.bbrc.2004.03.040
32. Tan, K. W.; Li, Y.; Paxton, J. W.; Birch, N. P.; Scheepens, A. Identification of novel dietary phytochemicals inhibiting the efflux transporter breast cancer resistance protein (BCRP/ABCG2) Food Chem. 2013, 138 (4) 2267-74 10.1016/j.foodchem.2012.12.021
33. Zhang, S.; Yang, X.; Coburn, R. A.; Morris, M. E. Structure activity relationships and quantitative structure activity relationships for the flavonoid-mediated inhibition of breast cancer resistance protein Biochem. Pharmacol. 2005, 70 (4) 627-39 10.1016/j.bcp.2005.05.017
34. Ahmed-Belkacem, A.; Pozza, A.; Munoz-Martinez, F.; Bates, S. E.; Castanys, S.; Gamarro, F.; Di Pietro, A.; Perez-Victoria, J. M. Flavonoid structure-activity studies identify 6-prenylchrysin and tectochrysin as potent and specific inhibitors of breast cancer resistance protein ABCG2 Cancer Res. 2005, 65 (11) 4852-60
35. Pick, A.; Muller, H.; Mayer, R.; Haenisch, B.; Pajeva, I. K.; Weigt, M.; Bonisch, H.; Muller, C. E.; Wiese, M. Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP) Bioorg. Med. Chem. 2011, 19 (6) 2090-102 10.1016/j.bmc.2010.12.043
36. Conseil, G.; Baubichon-Cortay, H.; Dayan, G.; Jault, J. M.; Barron, D.; Di Pietro, A. Flavonoids: a class of modulators with bifunctional interactions at vicinal ATP- and steroid-binding sites on mouse P-glycoprotein Proc. Natl. Acad. Sci. U. S. A. 1998, 95 (17) 9831-6 10.1073/pnas.95.17.9831
37. Matsson, P.; Englund, G.; Ahlin, G.; Bergstrom, C. A.; Norinder, U.; Artursson, P. A global drug inhibition pattern for the human ATP-binding cassette transporter breast cancer resistance protein (ABCG2) J. Pharmacol. Exp. Ther. 2007, 323 (1) 19-30 10.1124/jpet.107.124768
38. Pedersen, J. M.; Matsson, P.; Bergstrom, C. A.; Norinder, U.; Hoogstraate, J.; Artursson, P. Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2) J. Med. Chem. 2008, 51 (11) 3275-87 10.1021/jm7015683
39. Wissel, G.; Kudryavtsev, P.; Ghemtio, L.; Tammela, P.; Wipf, P.; Yliperttula, M.; Finel, M.; Urtti, A.; Kidron, H.; Xhaard, H. Exploring the structure-activity relationships of ABCC2 modulators using a screening approach Bioorg. Med. Chem. 2015, 23 (13) 3513-25 10.1016/j.bmc.2015.04.029
40. Fleisher, B.; Unum, J.; Shao, J.; An, G. Ingredients in fruit juices interact with dasatinib through inhibition of BCRP: a new mechanism of beverage-drug interaction J. Pharm. Sci. 2015, 104 (1) 266-75 10.1002/jps.24289
41. Chen, Z.; Zheng, S.; Li, L.; Jiang, H. Metabolism of flavonoids in human: a comprehensive review Curr. Drug Metab. 2014, 15 (1) 48-61 10.2174/138920021501140218125020
42. van Zanden, J. J.; Wortelboer, H. M.; Bijlsma, S.; Punt, A.; Usta, M.; Bladeren, P. J.; Rietjens, I. M.; Cnubben, N. H. Quantitative structure activity relationship studies on the flavonoid mediated inhibition of multidrug resistance proteins 1 and 2 Biochem. Pharmacol. 2005, 69 (4) 699-708 10.1016/j.bcp.2004.11.002
43. Lu, J. M.; Nurko, J.; Weakley, S. M.; Jiang, J.; Kougias, P.; Lin, P. H.; Yao, Q.; Chen, C. Molecular mechanisms and clinical applications of nordihydroguaiaretic acid (NDGA) and its derivatives: an update Med. Sci. Monit. 2010, 16 (5) RA93-100
44. Schutte, M. E.; Freidig, A. P.; van de Sandt, J. J.; Alink, G. M.; Rietjens, I. M.; Groten, J. P. An in vitro and in silico study on the flavonoid-mediated modulation of the transport of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) through Caco-2 monolayers Toxicol. Appl. Pharmacol. 2006, 217 (2) 204-15 10.1016/j.taap.2006.08.005
45. Zhang, S.; Morris, M. E. Effects of the flavonoids biochanin A, morin, phloretin, and silymarin on P-glycoprotein-mediated transport J. Pharmacol. Exp. Ther. 2003, 304 (3) 1258-67
46. van Zanden, J. J.; de Mul, A.; Wortelboer, H. M.; Usta, M.; van Bladeren, P. J.; Rietjens, I. M.; Cnubben, N. H. Reversal of in vitro cellular MRP1 and MRP2 mediated vincristine resistance by the flavonoid myricetin Biochem. Pharmacol. 2005, 69 (11) 1657-65 10.1016/j.bcp.2005.03.001
47. Deng, J. W.; Shon, J. H.; Shin, H. J.; Park, S. J.; Yeo, C. W.; Zhou, H. H.; Song, I. S.; Shin, J. G. Effect of silymarin supplement on the pharmacokinetics of rosuvastatin Pharm. Res. 2008, 25 (8) 1807-14 10.1007/s11095-007-9492-0
48. Wlcek, K.; Koller, F.; Ferenci, P.; Stieger, B. Hepatocellular organic anion-transporting polypeptides (OATPs) and multidrug resistance-associated protein 2 (MRP2) are inhibited by silibinin Drug Metab. Dispos. 2013, 41 (8) 1522-8 10.1124/dmd.113.051037
49. Miranda, S. R.; Lee, J. K.; Brouwer, K. L.; Wen, Z.; Smith, P. C.; Hawke, R. L. Hepatic metabolism and biliary excretion of silymarin flavonolignans in isolated perfused rat livers: role of multidrug resistance-associated protein 2 (Abcc2) Drug Metab. Dispos. 2008, 36 (11) 2219-26 10.1124/dmd.108.021790
50. Zhang, S.; Morris, M. E. Effect of the flavonoids biochanin A and silymarin on the P-glycoprotein-mediated transport of digoxin and vinblastine in human intestinal Caco-2 cells Pharm. Res. 2003, 20 (8) 1184-91 10.1023/A:1025044913766
51. Tian, X. J.; Yang, X. W.; Yang, X.; Wang, K. Studies of intestinal permeability of 36 flavonoids using Caco-2 cell monolayer model Int. J. Pharm. 2009, 367 (1-2) 58-64 10.1016/j.ijpharm.2008.09.023
52. Tammela, P.; Laitinen, L.; Galkin, A.; Wennberg, T.; Heczko, R.; Vuorela, H.; Slotte, J. P.; Vuorela, P. Permeability characteristics and membrane affinity of flavonoids and alkyl gallates in Caco-2 cells and in phospholipid vesicles Arch. Biochem. Biophys. 2004, 425 (2) 193-9 10.1016/j.abb.2004.03.023